Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00EMF
|
||||
Former ID |
DIB020905
|
||||
Drug Name |
SB 242084
|
||||
Synonyms |
SB-242,084; SB242084
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539229] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H19ClN4O2
|
||||
InChI |
InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27)
|
||||
InChIKey |
GIUZEIJUFOPTMR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Antagonist | [534428] | |
5-hydroxytryptamine 2A receptor | Target Info | Antagonist | [534428] | ||
5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [534428] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.